Heart Failure with Preserved Ejection Fraction and Geriatric Cardiology
Our lab has many ongoing HFpEF clinical trials, ranging from single-center, investigator-initiated research to large scale, multi-center trials.
Biomarkers and Metabolomics
Our lab has investigated the strengths and limitations of current biomarkers for risk prediction and cardiovascular screening.
Implementation Science and Electronic Health Records
We have investigated novel, EHR integrated strategies to advise clinicians on risk of adverse outcomes among patients with diabetic cardiomyopathy.
Big Data, Risk Prediction and Epidemiology
Our lab uses big-data approaches to predict risk of heart failure that can be used to identify who may benefit from effective preventive therapies. We have also developed novel risk-prediction models to better predict risk of cardiovascular diseases.
Health Services and Disparities
Our lab has a focus on answering clinical questions related to the determinants of cardiovascular disease in older adults.